📢There's a sound rationale for increased #collaboration among 🇪🇺countries in the procurement of health technologies!

🎗️On #WorldCancerDay , read how to build strong collaboration to achieve #FairPrices4Meds 👇

🔎bit.ly/3xZjBWK
🔗bit.ly/3ozs1B7

Today there are many new therapies to treat rare or genetic diseases. But these often come with a high price tag. How can we ensure both #innovation and fair access?

Find out more 👉 bit.ly/3HQrvpa

📅🕑13 January, 14:00 CET

#OsloMedicinesInitiative

Executive Director of JAZMP is a breath of fresh air in the EU regulator panorama.
Serious as regulation must be, it doesn't shy away from digital innovation, regulatory flexibility and the importance of optimizing existing (often limited) resources.
#AESGPregconf2021

'The trust in the EU is higher than before - we need to use this momentum to increase the health level of EU citizens.' Momir Radulovic from JAZMP

Our panel about Research & Innovation to tackle #AMR is formed by:

▶️ A. López Navas, AEMPS
▶️ Marco Cavaleri, EU Medicines Agency
▶️Aleksandra Opalska, European Commission
▶️ Suzanne Edwards, Global AMR Research & Development (R&D) Hub
▶️ Momir Radulovic, JAZMP

#EUjamraiConf

Emer Cooke, EMA's Exec. Director: EMA's scientific opinion paves the way for the first marketing authorisation of a #COVID19vaccine in the EU with the corresponding safeguards, controls and obligations.

JAZMP podaja izjavo za javnost v zvezi z objavami ICIJ o varnosti medicinskih pripomočkov jazmp.si/obvestilo/news…

Today and tomorrow Ljubljana, the Slovenian capital, ZZZS and JAZMP are co-hosting 24th PPRI (Pharmaceutical Pricing and Reibursement Information, seated at GOeG, Vienna) expert meeting, with attendance of 24 states reps (EU and third countries), Eur.Commission, OECD and WHO.

V Ljubljani danes in jutri ZZZS in JAZMP gostita predstavnike 24 držav (članic EU, in tretjih držav), Evropske komisije, OECD in SZO (WHO) na strokovnem srečanju PPRI (Pharmaceutical Pricing and Reimbursement Information), s sedežem na dunajskem inštitutu za javno zdravje GOeG.

JAZMP gathers Healthcare Providers, Veterinarians, and Industry to the presentation of the Fourth Edition of the Formularium Slovenicum (FS 4.0) on Thursday, 25 October 2018, Hall A at the Chamber of Commerce and Industry of Slovenia, Dimičeva ulica 13, Ljubljana.

JAZMP organizira strokovno posvetovanje ob predstavitvi četrte izdaje Formulariuma Slovenicuma (FS 4.0), ki bo v četrtek, 25. oktobra 2018, v dvorani A na Gospodarski zbornici Slovenije, Dimičeva ulica 13 v Ljubljani

7 out of 10 countries with the lowest #vaccine #confidence are in Europe & 4 of them (France, Greece, Italy, and Slovenia) are in #EU

Vytenis Andriukaitis statement 👉europa.eu/!nw86yn
Reports published today 👉europa.eu/!Yt84UF

#VaccinesWork #EU Vaccines

Tomorrow, EMA will host a workshop on shaping regulatory science to 2025 to ensure that innovation delivers great solutions for #PublicHealth . Watch the live broadcast here from 08h30: bit.ly/2yUsYbZ. Engage in conversation by using #RegScience2025 .

European Commission has asked JAZMP to publish link to the Commission's, EMA's and HMA's joint letter to the stakeholders on the implementation of the Falsified Medicines Directive: jazmp.si/obvestilo/news…

Evropska komisija je zaprosila JAZMP za objavo njenega opozorila za deležnike glede njihovih obveznosti pri izvajanju EU zakonodaje o ponarejenih zdravilih ,ki se prične februarja 2019: jazmp.si/obvestilo/news…

JAZMP v zadevi Hondrocream objavlja še dodatek koristnimi informacijami, ki naj v naši skupnosti zmanjšajo tveganje, ki nastaja zaradi pojave nezakonitega in nevarnega oglaševanja tega nelegalnega zdravila: jazmp.si/obvestilo/news…

JAZMP podaja stališče in opozorilo morebitnim zainteresiranim kupcem zdravila Hondrocream (gre za nezakonit izdelek in za prepovedano zavajajoče oglaševanje) jazmp.si/obvestilo/news…

Čestitke ministru za zdravje dr. Samu Fakinu ob nastopu mandata! JAZMP

JAZMP warns demand-side stakeholders, ie. health care providers incl. hospital and community pharmacies, of their obligations in implementing the new EU falsified medicines legislation as of Feb.2019. jazmp.si/obvestilo/news…

JAZMP opozarja deležnike v slovenskem zdravstvu in lekarništvu glede njihovih obveznosti pri izvajanju EU zakonodaje o ponarejenih zdravilih od feb.2019 jazmp.si/obvestilo/news…